Versions Compared

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.

...

4/1/13 1pm

PUW3

 

General discussion

11/1/13 1pm

Levinsky

Joe

Maraviroc PK

18/1/13 1pm

PUW4

Andrezj

PKPD bridging of response between adults and children

25/1/13 1pm

PUW3

Lilia

Neutropenia following paediatric BMT

1/2/13 1pm

PUW1

Mirjam Trame

Use of PKPD modeling to guide HIV understanding and treatment

8/2/13 1pm

PUW3

Sami

Bioequivalence studies and genetic variability

15/2/13 1pm

PUW1

Liana

ErbB inhibition for PKD

22/2/13 1pm

PUW3

Alienor Berges (GSK)

 

1/3/13 1pm

PUW4

Rollo

CD4 reconstitution post BMT 

8/3/13 1pm

PUW3

Eva

Neogent update

15/3/13 1pm

PUW4

Tafi

Dose individualisation in HIV/AIDS and TB patients on Efavirenz (EFV).

22/3/13 1pm

PUW3

Hui Ma

Genetic components to glucose-insulin response

26/4/13 1pm

PUW3

Sarit

FA and bioavailability

10/5/13 1pm

PUW3

Tafi

Common adverse drug reactions linked to HIV and/or TB medication: Lipodystrophy, Skin Hypersensitivity, CNS and Peripheral Neuropathy.
(To appear in the Journal of AIDS and Clinical Research, 2013).

28/5/13 1pm

PUW1

Charlotte

Use of meta-analysis in evidence synthesis: an example  based on dose selection for antibiotics (PAGE talk)

31/5/13 1pm

PUW1

Rollo

Modelling immune reconstitution in children post HSCT (PAGE talk)

7/6/13 1pm

PUW3

Julie

Penalized regression implementation within the SAEM algorithm to advance high-throughput personalized drug therapy (PAGE talk)

21/6/13 1pm

PUW1

Bruce Green

Therapeutic Drug Monitoring

16/9/13 1pm

PUW3

Joe

Diagnostics for bivariate regression models

23/9/13 1pm

PUW3

No meeting

Julie Seminar on Tues 24/9.

30/9/13 1pm

PUW2

Jan-Stefan Van der Walt

Nonlinear mixed effects model for saliva cortisol and cortisone in patients with Addisons disease and healthy volunteers.

1/10/13 1pm EXTRA MEETING

PUW4

Stefanie Hennig

Changes in between subject variability with covariate models in pharmacometrics

7/10/13 1pm

PUW2

 

 

14/10/13 1pm

PUW3

Tafi

TBA

21/10/13 1pm

PUW2

Julie

Modelling of tenofovir and emtricitabine PK in the ANRS 134-COPHAR 3 trial (work in progress)

28/10/13 1pm

PUW3

Joanna

CD4 recovery in the CHER study

4/11/13 1pm

PUW2

Eva

Upgrade talk practice

11/11/13 1pm

PUW3

Flora Musuamba

Use of modelling and simulation tools to improve decision-making in drug development and clinical practice

18/11/13 1pm

PUW2

Joe

Decision theory and antimicrobials

25/11/13 1pm

PUW3

Andreas

Pain PKPD

2/12/13 1pm

TWC F

No meeting

 

9/12/13 1pm

PUW3

Pieter de Cock

Paediatric antimicrobial PKPD in ICU

16/12/13 1pm

PUW3

Rollo

Modelling TCR repertoire (not with NLME!)